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Abstract 
 
Objective:    ​Despite decades of epilepsy research, 30% of focal epilepsies remain resistant to 
anti-seizure drugs, with effective drug development impeded by lack of understanding on how 
seizures are initiated. Here we report the mechanism of seizure onset relevant to most seizures 
characteristic for focal epilepsies. 
Methods:    ​Electric and metabolic network parameters were measured using several seizure 
models in mouse hippocampal slices and acutely-induced seizures in rats ​in-vivo ​to determine 
metabolic events occuring at seizure onset. 
Results:    ​We show that the seizure onset is associated with a rapid release of H​2​O​2​ resulting from 
NMDA receptor-mediated activation of NADPH oxidase (NOX). NOX blockade prevented the fast 
H​2​O​2​ release as well as the DC shift and seizure-like event induction in slices. Similarly, 
intracerebroventricular injection of NOX antagonists prevented acutely induced seizures in rats.  
Interpretation:    ​Our results show that seizures are initiated by NMDA receptor-mediated 
NOX-induced oxidative stress and can be arrested by NOX inhibition. We introduce a novel use 
for blood-brain barrier-permeable NOX inhibitor with a significant potential to become the first 
seizure-specific medication. Thus, targeting NOX may provide a breakthrough treatment for focal 
epilepsies. 
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1   Introduction 
 
A major goal of contemporary epilepsy research is the discovery of therapies that would prevent the 
development of recurrent seizures in individuals at risk.​ ​However,​ ​despite the availability of at least 22 
anti-seizure drugs ​(​1​)​, about 30% of patients with epilepsy remain resistant to drug therapy and continue 
to have seizures ​(​2​)​. Moreover, the proportion of those not becoming seizure-free despite treatment has 
not decreased substantially over the past 50 years ​(​3​)​. A lack of knowledge on molecular mechanism of 
seizure initiation impedes the development of targeted seizure therapy and modern anti-seizure drugs 
therefore mostly target general brain excitability ​(​4​)​. 
 
In patients with temporal lobe epilepsy, clinical intracranial EEG recordings using DC-coupled 
amplifiers revealed two major distinct EEG seizure onset patterns characterized by hypersynchronous or 
low voltage fast activity (LVF), each likely underlined by distinct pathological mechanisms ​(​5​)​. The low 
voltage fast activity pattern occurs in majority of seizures and often starts with a high-amplitude spike 
(sentinel spike) followed by a pronounced DC shift ​(​6​–​11​)​. Similar seizure onset was also reported for 
most ​ex vivo​ animal models using various seizure-inducing protocols ​(​12​–​14​)​, for human brain slices 
(​15​–​17​)​ and for ​in vivo​ acute and chronic animal models ​(​18​)​. The critical issue for understanding the 
seizure onset is what processes associated with the sentinel spike may trigger the following DC shift and 
the subsequent seizure. To address this question, we simultaneously measured electric (local field 
potentials, LFPs) and metabolic (extracellular oxygen, glutamate, H​2​O​2​) network parameters in 
hippocampal slices using several ​in vitro​ seizure models and verified the results ​in vivo​ in rats. 
 
2   Methods 
All animal protocols and experimental procedures were approved by the INSERM Ethics Committee for 
Animal Experimentation (#30-03102012). 
 
Tissue slice preparation 
Ex-vivo local field potential (LFP) recordings were performed on brain slices from P21-56 OF1 male 
mice (Charles River Laboratories, France). ​ ​A mouse anaesthetized with isoflurane was decapitated; the 
brain was rapidly removed from the skull and placed in the ice-cold ACSF. The ACSF solution 
consisted of (in mmol/L): NaCl 126, KCl 3.50, NaH​2​PO​4​ 1.25, NaHCO​3​ 25, CaCl​2​ 2.00, MgCl​2​ 1.30, 
and dextrose 5, pH 7.4. ACSF was aerated with 95% O2/5% CO2 gas mixture. Sagittal slices (350 µm) 
were cut using a tissue slicer (Leica VT 1200s, Leica Microsystem, Germany). During cutting, slices 
were submerged in an ice-cold (< 6°C) solution consisting of (in mmol/L): K-gluconate 140, HEPES 10, 
Na-gluconate 15, EGTA 0.2, NaCl 4, pH adjusted to 7.2 with KOH. Slices were immediately transferred 
to a multi-section, dual-side perfusion holding chamber with constantly circulating ACSF and allowed to 
recover for 2h at room temperature (22°C-24°C).  
 
Synaptic stimulation and field potential recordings 
Slices were transferred to a recording chamber continuously superfused (10 ml/min) with ACSF 
(33–34°C) with access to both slice sides. Schaffer collateral/commissures was stimulated using the 
DS2A isolated stimulator (Digitimer Ltd, UK) with a bipolar metal electrode. Stimulus current was 
adjusted using single pulses (40-170 µA, 200µs, 0.15 Hz ) to induce a LFP of about 50% maximal 
amplitude. LFPs were recorded using glass microelectrodes filled with ASCF, placed in stratum 
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pyramidale of CA1 area and connected to the ISO DAM-8A amplifier (WPI, FL). Synaptic stimulation 
consisted of a stimulus train (200µs pulses) at 100 Hz lasting 1s. 
 
Oxygen, glutamate and H​2​O​2​ measurements 
A Clark-style oxygen microelectrode (Unisense Ltd, Denmark) was used to measure slice tissue pO​2​, 
while extracellular H​2​O​2​ was measured with Null sensor (Sarissa Biomedical, Coventry, UK) as 
described elsewhere 14. Extracellular glutamate was measured using enzymatic microelectrodes (Sarissa 
Biomedical, Coventry, UK) connected to a free radical analyzer TBR4100 (Word Precision Instruments 
Ltd, UK).  
 
Pharmacology 
Antagonists of NMDA receptors, (2R)-amino-5-phosphonopentanoate (APV) and kynurenic acid; 
antagonist of AMPA/kainate receptors, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and GABAA 
receptors, bicuculline, were purchased from Tocris Bioscience (Bio-Techne Ltd, UK); 4-aminopyridine 
(4-AP) and Celastrol were purchased from Sigma-Aldrich (Sigma-Aldrich Chimie S.a.r.l.); 
GSK2795039 from MedChemExpress Europe.  
 
In Vivo Experiments  
19 mature Wistar male rats (300-400g) were used for ​in vivo​ experiments. Animals were anesthetized 
with pentobarbital (35mg/kg) supplemented with xylazine (10 mg/kg). Body temperature was kept at 
37°C using a heating pad. Rats were placed in a stereotaxic frame, scalped and holes for electrodes and 
guide cannula were drilled. Extracellular nichrome electrode (Ø 25µm) was implanted in hippocampal 
CA1 field (stereotaxic coordinates AP=-3.2mm, L= 2mm, H=3.5 mm), guide cannula for drug injection 
was implanted just above lateral ventricle (AP=0.8mm, L= 1.7mm, H=2.3 mm). Stereotaxic coordinates 
were set according to Paxinos and Watson rat brain atlas (The Rat Brain in Stereotaxic Coordinates, 6th 
edition). Electrocoagulation was used to verify electrode and cannula placements. Indifferent electrode 
was screwed into occipital bone. In experiments with H​2​O​2​ sensor, additional cranial window (Ø 2mm) 
above contralateral hippocampus was drilled and sensor was dipped in hippocampus (3.5mm) using 
stereotaxic manipulator. After surgical preparation, the cortex was kept under saline to prevent drying. 
Stereotaxic frame was transferred to electrophysiological setup and recordings started. LFPs were 
amplified (Grass Instrument, U.S.A.), filtered (high-pass filter 0.01 Hz, digitized at 5 kHz), and stored 
using DataPack2k software (RUN Technologies, USA). H​2​O​2​ sensor (Sarissa probe) was polarized 
+500mV and recorded using potentiostat (Diamond Electrotech). Following 10 min recordings of 
control activity either 7µg of 4-AP  in 1µL saline or 0.1µg of kainate (KA) in 2µL was injected i.c.v. 
using Hamilton syringe to induce seizure activity. After induction of stable seizure activity (at least 1 
seizure episode per 5 min, from 30 to 60 min after 4-AP/KA injection) drugs were injected i.c.v. (APV 
4µg  in 1µL saline, GSK2795039 45µg in 1µL DMSO, celastrol 72µg in 2µL DMSO). 
 
For spontaneous seizure detection, we used automated computer analysis of LFP recordings with the 
following selection limits: seizure threshold 7*RMS (root mean square) of baseline; number of 
oscillations in a scanning window (5 s) exceeding the threshold no less than 10; minimal seizure 
duration 10 s; time interval between seizures no less than 3 s.  
 
For low frequency (DC) shift analysis representative episodes 300s long in each experiment in control, 
after 4-AP/KA and after drug injection were chosen. LFPs were filtered from 0 to 1 Hz, the average LFP 
Malkov et al. Ann. Neurol  Accepted 
3 
Activation of NADPH oxidase triggers seizures 
 
amplitude was set as zero and the negative component of LFP was reflected against zero. DC line index 
was calculated as an area (integral) under resulting curve normalized to control values. 
 
Statistical analysis and signal processing 
Group measures were expressed as means ±SEM. Statistical significance was 
assessed using the Wilcoxon's signed paired test and the Wilcoxon Rank-Sum test.  
Significance level was set at p<0.05. Correlation between two variables was calculated using Pearson's 
correlation coefficient (r). Signal analysis was performed using the IgorPro software (WaveMetrics, Inc., 
USA) with custom developed macros.  
 
3   Results 
Glutamate-induced activation of NOX triggers seizures in hippocampal slices 
Experiments in acute brain slices were performed using a 4-AP seizure model (n = 36) with results 
reproduced using bicuculline (n = 3) and 
low-Mg (0.1 mM; n = 12) seizure models. 
 
Fig. 1.​ ​Extracellular H​2 ​O​2​ and glutamate during 
epileptiform activity induced by 4-AP in 
hippocampal slices.  
A.​ Glutamate release and H​2​O​2​ production are 
associated with interictal spikes. Inset (c) shows 
power spectral density (PSD) of selected 
“complex” (black) and “simple” (gray) spikes. ​B. 
All spontaneous seizures were preceded by a 
“complex” spike associated with a fast, high 
amplitude release of H​2​O​2​. Top: representative 
traces of field potential recordings (black) and 
associated extracellular H​2​O​2​ release (green). 
Inserts below shows field potential traces of 
selected seizures (black) with superimposed 
records (below) of LFP, H​2​O​ 2 ​(green) and 
extracellular glutamate (red) corresponded to the 
seizure onset shown at expanded time scale. Note 
that the considerable difference in scale creates an 
illusion of "leading" H​2​O​ 2 ​ signal over the 
glutamate one. ​C.​ Dependence of H​2​O​2​  and 
glutamate releases versa amplitudes of the first 
(left) and the second (right) spikes in the complex 
spike potential.   Note that both glutamate and 
H​2​O​2​ peaks were correlated with the amplitude of 
the second but not the first component in the spike 
complex.  Insets show superimposed traces of 
field potential and H​2​0​2​ release, demonstrating 
strong dependence of this release on the second 
spike. ​D.​ Relationship between glutamate and 
H​2​O​2​ releases during the same epileptiform spikes. 
Note the correlation between these values. ​E. 
Summary histogram of H​2​O​2​ release amplitudes 
during epileptiform spikes. Red line indicates a presumable threshold above which seizures are induced. 
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Enhanced efficacy of both excitatory and inhibitory transmissions induced by 4-AP ​(​19​)​ resulted in 
hippocampal network hyperexcitability manifested as interictal activity (Fig. 1A). Interictal discharges 
displayed two major patterns which we defined either as “simple” or “complex” spikes (Fig. 1A: 
(a)-complex, (b)-simple). The complex spikes normally consisted of two or more closely spaced voltage 
peaks, while a “simple” spike was one peak only. All recorded spontaneous seizure-like events (SLEs) 
were preceded by a complex spike that was followed by DC shift (Fig. 1B, insets: arrows).  
 
Fig. 2.​ ​AMPA/KA receptor, K​+​-Cl​-​ co-transporters or 
GABAergic transmission blockade does not prevent the 
DC-shift induction.  
A. ​Superimposed records of field potential and H​2​O​2 
transients at 100Hz, 1s stimulation of Schaffer 
collaterals in control ACSF (left) and under 4-AP 
(induced seizure, middle), and during spontaneous 
seizure (right). Note that H​2​O​2 ​release triggered by 
100Hz stimulation exhibits a biphasic shape 
characterized by an initial rapid peak (red arrows) 
followed by a delayed, slower and larger release. This 
second component was absent in case of spontaneous 
SLEs, therefore was not associated with seizure 
induction. ​B-D.​ Neither blockade of AMPA/kainаte 
receptors (B, n = 4) nor blockade of K​+​-Cl​- 
co-transporters (C, n = 3) or inhibitory transmission (D, 
n = 3) prevented the DC shift associated with rapid high 
release of H​2​O​2​. Note in (D) spontaneous seizure 
preceded by a complex spike with following DC shift 
despite the blockade of GABAergic transmission. 
 
 
Simultaneous field (black), extracellular 
glutamate (red) and H​2​O​2​ (green) 
measurements (Fig. 1B, lower traces) revealed 
that the complex spikes were associated with 
an especially high and fast production of H​2​O​2 
as well as an augmented release of glutamate; 
both glutamate and H​2​O​2 ​peaks were correlated 
with the amplitude of the second but not the 
first spike in the complex (Fig. 1C). 
Accordingly, the spike-induced H​2​O​2 
production was positively correlated with the 
release of glutamate (Fig. 1D).  The 
distribution of H​2​O​2​ peaks induced by interictal 
activity (Fig. 1E) revealed a presumable 
threshold value (red line) for subsequent DC 
shift and SLE initiation.  
 
Taken together, these results suggest that SLE induction requires an interictal event of a specific profile 
- the complex spike - associated with suprathreshold release of H​2​O​2​.  To investigate such a causal link, 
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we replicated spontaneous SLEs using a 100Hz, 1s stimulation of Schaffer collaterals under 4-AP 
application ​(​20​)​. Spontaneous SLEs were observed in 44% of experiments, while synaptic stimulation 
successfully induced SLEs in each slice.  In control ACSF, such stimulation normally resulted in an 
initial, rapid and small-amplitude production of H​2​O​2​ followed by a delayed (a few seconds) and a much 
larger but slow increase in extracellular H​2​O​2 ​concentration (Fig. 2A, left, green trace). Since the last 
component was characteristic for the stimulation of Schaffer collaterals but was absent during 
spontaneous SLEs (Fig. 2A, right), its origin is likely related to the intracellular (mitochondrial) 
generation of reactive oxygen species (ROS) during en-masse activation of Schaffer collaterals. 
Therefore, we focused primary attention on the initial fast H​2​O​2​ transient presumably directly related to 
SLE induction. We also attempted to 
elucidate  the origin of DC shift that is 
an inherent feature of SLEs. 
 
Fig. 3.​ ​NOX antagonists ablate  fast H​2​O​2 
production and prevent DC shift and seizure 
induction.  
A-B. ​Upper traces:​ Decrease of interictal 
activity-associated release of H​2​O​2​ following 
inhibition of NOX. Superimposed records of 
field potential (gray) and H​2​O​2​ release (green) 
during interictal activity induced by 4-AP (left) 
and following addition of APV (​A​, right) or 
celastrol (​B​, right). Note that neither APV nor 
celastrol affected significantly LFP induced by a 
single stimulation of Schaffer collaterals (insets 
on the right). ​Lower traces:​ LFP and 
extracellular  H​2​O​2​ transients at 100Hz, 1s 
stimulation of Schaffer collaterals under 4-AP. 
Blockade of NMDA receptors by APV (​A​) or of 
NOX by celastrol (​B​) abolished both the rapid 
H​2​O​2​ production (red arrows; A: n = 15; B: n = 
7) and the associated DC shift.  
 
Glutamate spillover during synaptic 
activity could potentially activate 
extra-synaptic receptors and thus induce 
secondary slow network depolarization 
resulting in the observed DC shift. 
However, application of CNQX (40μM), 
a potent antagonist of AMPA/KA 
receptors, inhibited the interictal activity 
but affected neither the fast H​2​O​2​ release 
nor the DC shift induced by synaptic 
stimulation (Fig. 2B). Indeed, CNQX 
prevents activation of postsynaptic 
AMPA/KA receptors, thus excluding the contribution of these receptors to the DC-shift. However, 
CNQX does not affect the presynaptic glutamate release during Schaffer collaterals stimulation, and 
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presumably exactly this glutamate activates fast H​2​O​2​ release with a consequent induction of the 
DC-shift (see below). 
 
Fig. 4.​ ​Fast H​2​O​2​ release and DC shift 
magnitudes depend on the efficacy of 
cellular cytoplasmic antioxidant defense. 
A.​ Interictal activity-induced fast H​2​O​2 
release is increased following replacement 
of glucose for pyruvate in ACSF (see 
H​2​O​2​ release records above). In 
pyruvate-ACSF, mitochondria have 
sufficient fuel for generation of ATP, 
however intracellular cytoplasmic pentose 
phosphate pathway dependent antioxidant 
defense is diminished due to the absence 
of glucose (see schematic). ​B.​ The DC 
shift is significantly enhanced in 
pyruvate-ACSF (n = 12). Graph on the 
right demonstrates summary of the DC 
shift amplitude in glucose-ACSF and 
pyruvate-ASCF solutions. 
 
Recent reports ​(​21​, ​22​)​ suggest KCC2 co-transporters as providers of enhanced extracellular K​+ 
responsible for the DC shift during seizure initiation. However, application of a cation-chloride 
co-transporter’s antagonist bumetanide (50μM, similar to that used in ​(​21​)​) failed to reduce H​2​O​2​ release 
and to prevent neither the DC shift nor SLE induction by stimulation (n = 3; Fig. 2C).  Note that 
bumetanide is not specific for the NKCC1 co-transporter only and at higher concentrations (50μM) also 
blocks KCC2 ​(​21​, ​23​)​. Finally, inhibition of GABAergic transmission by bicuculline (20μM) did not 
block spontaneous SLEs (n = 3; Fig. 2D) indicating that network synchronization by GABAergic 
neurotransmission is not mandatory for the SLE initiation.  
Thus, neither activation of extrasynaptic AMPA/KA receptors nor GABAergic transmission turned to be 
primary players in the SLE onset. Therefore, we investigated the role of fast H​2​O​2​ release in the SLE 
initiation.  
 
We supposed that rapid H​2​O​2​ production is underlain by the activation of NADPH oxidase (NOX), as 
NOX’s unique biological function is to generate ROS ​(​24​)​; NOX is expressed in membranes of both 
neurons, astrocytes and microglia and the NMDA receptor-dependent signaling is one of NOX 
activation pathways ​(​24​)​,​(​25​)​. Indeed, in our experiments a rise in extracellular glutamate preceding the 
SLE onset could be sufficient to activate NMDA receptors possessing high affinity to this 
neurotransmitter. Therefore, we tested the effects of NMDA or NOX antagonists on SLE generation. 
NMDA receptor blockade by APV did not prevent the interictal activity nor significantly affected 
synaptic transmission (Fig. 3A). Meanwhile, under APV rapid H​2​O​2​ production was substantially 
decreased during interictal events and was ablated at same stimulus that normally induced SLEs (Fig. 
3A, red arrows). Importantly, APV prevented both the subsequent DC shifts and SLEs (in 14 of 15 
experiments). Similarly, application of celastrol (40 μM), a potent NOX antagonist ​(​26​)​, affected neither 
the interictal activity nor synaptic transmission (Fig. 3B), while the fast H​2​O​2​ production was inhibited 
during interictal events and was almost eliminated at 100Hz stimulation. Celastrol also blocked the DC 
shifts and SLEs in 6 of 7 experiments.  
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Fig. 5​. Long-lasting hippocampal seizure activity induced in an anesthetized rat by intracerebroventricular 4-AP injection 
(7µg/1µL). Corresponding dynamics of seizure frequency and duration (right). Injection of 4-AP induced seizure activity 
stable for at least 2 hours. 
 
NMDA-NOX signaling role in SLE induction was further confirmed by brief direct application of 
NMDA onto CA1 stratum radiatum under 4-AP: NMDA-induced DC shifts and SLEs were observed 
(not shown; n = 3; see also ​(​27​)​) and were also prevented by celastrol. We conclude, therefore, that 
NOX activation via NMDA receptor signaling triggers a cascade of events initiating the DC shift and the 
subsequent SLE.  
 
Direct involvement of ROS in the process of SLE initiation and DC shift generation was further 
confirmed by the experiments with substitution of ACSF glucose with pyruvate that weakened the 
cytoplasmic antioxidant defense system ​(​28​)​ (see schematics in Fig. 4A). In pyruvate-ACSF, the fast 
H​2​O​2​ production during interictal events was significantly enhanced (Fig. 4A). Moreover, the DC shift 
during both the induced and spontaneous SLEs was increased (Fig. 4B), presumably due to higher 
extracellular K​+ ​concentration ​(​28 ​)​.  
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Fig. 6.​ ​NOX inhibition reduces seizure activity in vivo.​ A-C.​ LFP recordings in hippocampus of anesthetized rats. 
Intracerebroventricular injection of 4-AP induced regular ictal discharges (red, see also Fig. 5; n = 13) that were suppressed 
by application of NMDA antagonist APV (A; 4µg/1µL; n = 4) or by inhibition of NOX with GSK2795039 (B; 45µg/1µL; n = 
5) or celastrol (C; 72µg/2µL; n = 4). (​Aa)​ and (​Bb) ​demonstrate long-lasting field recordings (gray) with the inserted black 
traces representing field recordings low-pass filtered at 1Hz, that shows clearly  ultra-slow baseline deviations during seizure 
activity. ​ ​ (​C​) also demonstrates extracellular H​2​O​2​ release (green) and distribution of H​2​O​2​ peak amplitudes. ​D.​ Summary of 
in vivo​ experiments. The DC line index represents the low-frequency deviation from the LFP baseline (see Methods). 
 
Acute seizures in vivo are prevented by NOX antagonists 
To verify the results obtained in slices we induced acute seizures in anesthetized rats by 
intracerebroventricular injection of 4-AP ​(​29​)​.  Epileptic discharges started shortly (a few minutes) 
following 4-AP injection and lasted for more than two hours without decrementing (Fig. 5). We tested 
the efficacy of three NOX antagonists possessing different mechanisms of action ​(​30​, ​31​)​ – APV ​(​25​)​, 
celastrol ​(​26​)​ and GSK2795039 ​(​31​)​ on inhibition of seizures (Fig. 6). All three antagonists strongly 
reduced seizure activity (Fig. 6D). Importantly, GSK2795039 is a novel small molecule selective direct 
inhibitor of NOX2 with efficiency demonstrated ​in vivo​ and with brain bioavailability demonstrated at 
oral administration ​(​31​)​. Therefore, it possesses significant therapeutic potential for the development of 
anti-seizure medication.  
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Fig. 7. A. ​Long-lasting hippocampal seizure activity induced in an anesthetized rat by intracerebroventricular kainate 
injection . ​B. ​Inhibition of kainate-induced seizures by celastrol (72µg/2µL; n = 3). Upper trace demonstrates long-lasting 
field recordings (gray) with an inserted black trace representing field recording low-pass filtered at 1Hz, clearly showing 
ultra-slow baseline deviations during seizure activity. 
 
To ensure that the NOX antagonists’ anti-ictogenic effects are not specific for the 4-AP-induced seizures 
only, as an alternative we induced seizure activity by i.c.v. injection of kainate (KA).  KA has been 
widely used to induce acute brain seizures via activation of KA receptors expressed in both neurons and 
astrocytes ​(​32​)​. In all experiments (n=6),  KA induced stable seizure activity (Fig. 7A). In three rats, 
celastrol was i.c.v. injected following the kainate-induced seizure activity: the average number of 
seizures under KA was (9.6 ± 1.85)/hour (average duration 27.6 ± 3.07 s); in all these slices seizure 
activity was completely abolished by application of  celastrol (Fig. 7B).  We conclude therefore that the 
NOX activation likely plays a dominating role in the onset of variety of acute seizures. Тhe effects of 
NOX inhibitors on seizures during chronic epilepsy remain to be elucidated and are the issue of future 
studies.  
 
4   Discussion 
 
About 30% of patients with focal epilepsy are drug-resistant ​(​2​)​, thus pharmacoresistance remains one 
of the biggest challenges in epilepsy treatment​. ​Understanding the mechanism of seizure onset is crucial 
for solving this problem. Although accumulation of ROS (oxidative stress) was implicated in 
epileptogenesis ​(​33​)​ and oxidative stress is in turn a consequence of seizures ​(​20​, ​34​)​, direct 
involvement of ROS in seizure initiation has never been demonstrated until now.  
 
Here we provide the first evidence that the glutamate-induced and NMDA-mediated activation of NOX 
is the main trigger for seizures that are typical for focal epilepsies ​(​6​, ​8​)​. Importantly, NOX2 
upregulation has been reported in surgical hippocampal specimens from a patient suffering from 
pharmacoresistant seizures ​(​35​)​. Although elucidation of the subsequent process of actual seizure 
generation is a matter of future studies, the available data allow us to propose the following sequence of 
events (Fig. 8B): NOX-induced oxidative stress transiently inhibits Na/K-ATPase ​(​36​)​, restricting the 
uptake of extracellular K​+​  (increased by several mM at the very beginning of seizure initiation ​(​19 ​)​) as 
well as the efflux of intracellular Na​+​, thus giving rise to focal network depolarization. The 
depolarization-induced additional K​+​ release as well as astrocytic glutamate release (e.g. Fig. 8A; see 
also ​(​37​)​) may further increase this depolarization. In addition, we observed significant tissue 
(astrocytic) swelling coincident at seizure onset with the sentinel spike (Fig. 8A; see also ​(​38​)​) that can 
augment the extracellular K​+​/glutamate concentrations even further by reducing extracellular volume. 
Together, these events presumably underlie the DC shift. Pyramidal cell firing during the repolarization 
phase of the DC shift may underlie the network synchronization and following ictal discharges. 
 
Considering the origin of complex spikes, interictal events initiating seizures may likely be induced by 
initial intensive spiking of interneurons. Indeed,  in slices under 4-AP, a brief (30ms) optogenetic 
interneuron stimulation evoked the appearance of interictal-like events and suggested that activation of 
interneurons recruits and entrains pyramidal cells ​(​39​)​; some of these stimuli also induced ictal events 
(​39​–​41​)​. ​In vivo​ animals with acute 4-AP application, optogenetic interneuron stimulation during the 
interictal phase readily induced seizures both in neocortex ​(​42​)​ and hippocampus ​(​39​)​.   Single-unit 
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recordings revealed that the powerful ictogenic effect of interictal interneuron activation probably 
resulted from rebound firing enhancement of pyramidal neurons following the optogenetic interneuron 
stimulation. In chronic epileptic animals, interneurons were preferentially recruited during spontaneous 
interictal activity in the CA1 region ​(​43​)​, as well as before and during ictal events ​(​44​)​. In patients with 
mesial– temporal lobe epilepsy during the onset of LVF seizures in hippocampus, inhibitory neurons 
dramatically increased their firing rate prior to an increase in excitatory neuron firing ​(​45​)​.  
 
Fig. 8. ​ ​Concurrent combination of 
several events is required for seizure 
induction. 
A. ​Both spontaneous and induced 
seizures are associated with tissue 
swelling. ​B. ​Schematic representation 
of events during seizure induction. 
See the main text for details. 
 
The general conclusion made 
from these data implies the 
dominating role of interneuron 
firing for the onset of both 
interictal and ictal events with 
the delayed pyramidal cell 
firing as the result of 
post-inhibition rebound 
excitation. In our case, one 
possible scenario for our 
observations is that the complex 
spikes represent the initial 
interneuron firing (first peak) 
with the second peak 
representing the delayed 
pyramidal cell firing with 
subsequent NOX activation and 
corresponding release of H​2​O​2​. 
Correlation of glutamate (as 
well as H​2​O​2​) release with the 
second peak amplitude but not 
with the first one validates such 
an assumption (Fig. 1C). 
Indeed, NOX2 is mainly 
expressed in pyramidal cells 
and microglia ​(​46​)​ while 
considering interneurons, available (although very limited) data report highly low (almost below 
sensitivity threshold) and much smaller than in pyramidal cells NOX2 expression ​(​47​)​. Worth noting is 
that we did observe the "complex" (consisting of several peaks) spikes in the presence of bicuculline. 
However, inhibition of GABAergic transmission does not itself prevent the interneuron firing; in 
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addition we have no evidence that these spikes have the same origin as those we observed in the 
presence of GABAergic transmission. As we suggested, enhanced pyramidal cell excitability due to the 
absence of inhibition may be involved in these spontaneous events.  
 
Considering the relevance of the NOX antagonists utilized in our study for a clinical application, NMDA 
receptor antagonists, e.g., dizocilpine or ketamine, inhibited seizures in experimental animals evoked by 
pentetrazole, pilocarpine, maximal electroshock or sensory stimulation ​(​48​)​. However, NMDA receptor 
blockade can affect multiple brain functions and therefore chronic administration of NMDA receptor 
inhibitors, APV or its analogs, would likely lead to severe side effects.  The therapeutic usefulness and 
anti-inflammatory properties of celastrol have been studied in several inflammatory diseases, including 
rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, inflammatory bowel disease, 
osteoarthritis, allergy and skin inflammation ​(​49​)​. However, despite the therapeutic potential of 
celastrol, clinical applications are limited by low water solubility, reduced oral bioavailability, narrow 
window of dosage, and adverse side effects ​(​50​)​. In contrast, GSK2795039 is not cytotoxic at 
concentrations efficacious for NOX2 inhibition ​(​31​)​. It has been shown that GSK2795039 is orally 
available and can be measured in the blood and central nervous system, suggesting that it can cross the 
blood–brain barrier. It fully inhibited NOX2 enzyme activity ​in vivo​ following systemic dosing in mice, 
while GSK2795039 effects were reversible since 24 h after administration. GSK2795039 was well 
tolerated by rodents, with no obvious adverse effects following 5 days of oral administration. However, 
the up to date information on GSK2795039 pharmacology is limited and the drug’s ​in vivo​ safety, 
pharmacokinetics and pharmacodynamics should be evaluated further in future studies.  
 
While considering the principal role of NOX-induced oxidative stress in seizure initiation, it is also 
important to note a failure of exogenous antioxidants to affect the fast H​2​O​2​ release. Indeed, as we 
demonstrated previously ​(​20​)​, neither Tempol nor apocynin (potent antioxidants) significantly affected 
the fast H​2​O​2​ transient, indicating that anti-seizure drug development should focus either on the 
enhancement of endogenous antioxidant defense and/or on direct antagonists of NOX. In addition, as 
expected, direct application H​2​O​2​ to quiescent slices either in ACSF perfusate or as short-lasting puffs 
(data not shown, see ​(​20​)​) failed to replicate the effects of NOX activation (the DC shift), indicating that 
a concurrent combination of several events, e.g. glutamate release and spillover inducing NOX 
activation and excessive release of K​+​ (see Fig. 8B) might be required for seizure induction. 
 
In summary, our present results reveal a specific trigger mechanism for seizure onset as well as ways to 
block it and thus to prevent seizures, with major implications for epilepsy treatment. 
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